Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mott

Showing results (241-250 of 254) with videos related to

Pageof 26
Sort By:
Cancer Reports (Hoboken, N.J.)|October 1, 2021
Characterizing academic performance in pediatric acute lymphoblastic leukemia with population-based achievement testsHend M Al-Kaylani, Erin E Reasoner, Bradley T Loeffler, et al.
Biomedicines|July 2, 2021
RABL6A Promotes Pancreatic Neuroendocrine Tumor Angiogenesis and Progression In VivoChandra K Maharjan, Shaikamjad Umesalma, Courtney A Kaemmer, et al.
Journal of Oncology Translational Research|December 17, 2016
Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung CancerAmir Zahra, Tangel Chang, Taher Abu Hejleh, et al.
Cancers|July 16, 2020
A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue SarcomasVarun Monga, Keith M Skubitz, Seth Maliske, et al.
Scientific Reports|October 23, 2020
High-throughput continuous-flow microfluidic electroporation of mRNA into primary human T cells for applications in cellular therapy manufacturingCharles A Lissandrello, Jose A Santos, Peter Hsi, et al.
Urologic Oncology|June 7, 2021
Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCGRyan L Steinberg, Vignesh T Packiam, Lewis J Thomas, et al.
Urologic Oncology|September 10, 2023
Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapyKendrick Yim, Kevin Melnick, Sarah L Mott, et al.
AIDS Research and Human Retroviruses|January 28, 2012
Short communication: Investigation of incident HIV infections among U.S. army soldiers deployed to Afghanistan and Iraq, 2001-2007Paul T Scott, Shilpa Hakre, Otha Myles, et al.
The Journal of Urology|December 11, 2019
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder CancerRyan L Steinberg, Lewis J Thomas, Nathan Brooks, et al.
Cancer Research|June 18, 2015
Pharmacological Ascorbate Radiosensitizes Pancreatic CancerJuan Du, John A Cieslak, Jessemae L Welsh, et al.
Pageof 26

Showing results (241-250 of 254) with videos related to

Sort By:
Pageof 26
Cancer Reports (Hoboken, N.J.)|October 1, 2021
Characterizing academic performance in pediatric acute lymphoblastic leukemia with population-based achievement testsHend M Al-Kaylani, Erin E Reasoner, Bradley T Loeffler, et al.
Biomedicines|July 2, 2021
RABL6A Promotes Pancreatic Neuroendocrine Tumor Angiogenesis and Progression In VivoChandra K Maharjan, Shaikamjad Umesalma, Courtney A Kaemmer, et al.
Journal of Oncology Translational Research|December 17, 2016
Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung CancerAmir Zahra, Tangel Chang, Taher Abu Hejleh, et al.
Cancers|July 16, 2020
A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue SarcomasVarun Monga, Keith M Skubitz, Seth Maliske, et al.
Scientific Reports|October 23, 2020
High-throughput continuous-flow microfluidic electroporation of mRNA into primary human T cells for applications in cellular therapy manufacturingCharles A Lissandrello, Jose A Santos, Peter Hsi, et al.
Urologic Oncology|June 7, 2021
Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCGRyan L Steinberg, Vignesh T Packiam, Lewis J Thomas, et al.
Urologic Oncology|September 10, 2023
Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapyKendrick Yim, Kevin Melnick, Sarah L Mott, et al.
AIDS Research and Human Retroviruses|January 28, 2012
Short communication: Investigation of incident HIV infections among U.S. army soldiers deployed to Afghanistan and Iraq, 2001-2007Paul T Scott, Shilpa Hakre, Otha Myles, et al.
The Journal of Urology|December 11, 2019
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder CancerRyan L Steinberg, Lewis J Thomas, Nathan Brooks, et al.
Cancer Research|June 18, 2015
Pharmacological Ascorbate Radiosensitizes Pancreatic CancerJuan Du, John A Cieslak, Jessemae L Welsh, et al.
Pageof 26